Standard
Harvard
Zerkalenkova, E, Lebedeva, S, Borkovskaia, A, Soldatkina, O, Plekhanova, O
, Tsaur, G, Maschan, M, Maschan, A, Novichkova, G & Olshanskaya, Y 2021, '
BTK, NuTM2A, and PRPF19 are novel KMT2A partner genes in childhood acute leukemia',
Biomedicines, vol. 9, no. 8, 924.
https://doi.org/10.3390/biomedicines9080924APA
Zerkalenkova, E., Lebedeva, S., Borkovskaia, A., Soldatkina, O., Plekhanova, O.
, Tsaur, G., Maschan, M., Maschan, A., Novichkova, G., & Olshanskaya, Y. (2021).
BTK, NuTM2A, and PRPF19 are novel KMT2A partner genes in childhood acute leukemia.
Biomedicines,
9(8), [924].
https://doi.org/10.3390/biomedicines9080924Vancouver
Author
BibTeX
@article{20832047f671415092edd1f343b3f1c0,
title = "BTK, NuTM2A, and PRPF19 are novel KMT2A partner genes in childhood acute leukemia",
keywords = "Cytogenetics, Fusion genes, KMT2A, NGS, Pediatric acute leukemia, fusion genes, MOLECULAR-GENETICS, ACTIVATION, SPLICEOSOME, cytogenetics, CELL-SURVIVAL, IDENTIFICATION, CYTOGENETICS, TRANSCRIPTS, BRUTONS TYROSINE KINASE, RT-PCR, pediatric acute leukemia, MYELOID-LEUKEMIA",
author = "Elena Zerkalenkova and Svetlana Lebedeva and Aleksandra Borkovskaia and Olga Soldatkina and Olga Plekhanova and Grigory Tsaur and Michael Maschan and Aleksey Maschan and Galina Novichkova and Yulia Olshanskaya",
note = "Funding Information: Funding: KMT2A rearrangement assessment was supported by the Russian Science Foundation (grant no. 19-75-10056). Quantitative RT-PCR for MRD monitoring was supported by Russian Presidential (grant no. MK-1645.2020.7). Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = aug,
doi = "10.3390/biomedicines9080924",
language = "English",
volume = "9",
journal = "Biomedicines",
issn = "2227-9059",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "8",
}
RIS
TY - JOUR
T1 - BTK, NuTM2A, and PRPF19 are novel KMT2A partner genes in childhood acute leukemia
AU - Zerkalenkova, Elena
AU - Lebedeva, Svetlana
AU - Borkovskaia, Aleksandra
AU - Soldatkina, Olga
AU - Plekhanova, Olga
AU - Tsaur, Grigory
AU - Maschan, Michael
AU - Maschan, Aleksey
AU - Novichkova, Galina
AU - Olshanskaya, Yulia
N1 - Funding Information: Funding: KMT2A rearrangement assessment was supported by the Russian Science Foundation (grant no. 19-75-10056). Quantitative RT-PCR for MRD monitoring was supported by Russian Presidential (grant no. MK-1645.2020.7).
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/8
Y1 - 2021/8
KW - Cytogenetics
KW - Fusion genes
KW - KMT2A
KW - NGS
KW - Pediatric acute leukemia
KW - fusion genes
KW - MOLECULAR-GENETICS
KW - ACTIVATION
KW - SPLICEOSOME
KW - cytogenetics
KW - CELL-SURVIVAL
KW - IDENTIFICATION
KW - CYTOGENETICS
KW - TRANSCRIPTS
KW - BRUTONS TYROSINE KINASE
KW - RT-PCR
KW - pediatric acute leukemia
KW - MYELOID-LEUKEMIA
UR - http://www.scopus.com/inward/record.url?scp=85112617674&partnerID=8YFLogxK
UR - https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=tsmetrics&SrcApp=tsm_test&DestApp=WOS_CPL&DestLinkType=FullRecord&KeyUT=000688995200001
U2 - 10.3390/biomedicines9080924
DO - 10.3390/biomedicines9080924
M3 - Article
AN - SCOPUS:85112617674
VL - 9
JO - Biomedicines
JF - Biomedicines
SN - 2227-9059
IS - 8
M1 - 924
ER -
